Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Enphase Energy's director, Richard Mora, conducted a transaction involving the sale of company stock. This activity was reported alongside recent operational news for Enphase, including technology launches and pre-order agreements. Furthermore, the sector saw movement from competitors like SolarEdge Technologies following strong earnings reports fr…
Roth Capital Partners began coverage of SailPoint, Inc. on May 20, assigning a "Buy" rating and a 12-month price target of $19. The firm values the company at roughly 7x FY2028 enterprise value-to-sales, views the stock as discounted versus cybersecurity peers, and highlights a roughly $1 billion ARR run rate against an estimated $55 billion addres…
Galaxy Digital director Michael Daffey sold approximately $7.19 million worth of Class A common stock after exercising options on May 21, 2026. This transaction occurred against a backdrop of mixed market performance for the ticker, though the company recently reported strong first-quarter results and secured key strategic partnerships.
Peter Altman, President and CEO of BioCardia, Inc. (NASDAQ:BCDA), recently acquired a notable amount of the company's common stock over two separate days in May 2026. These insider purchases occurred while the stock was trading close to its 52-week low. Separately, BioCardia reported significant operational improvements and strategic clinical advan…
Remitly Global's director, Bora Chung, reported the sale of 12,000 shares of common stock. This insider transaction occurred against a backdrop of positive corporate developments, including the company surpassing market expectations for its first-quarter 2026 earnings and announcing new service features in both the US and Canada.
American States Water Co.'s director, Anne M. Holloway, recently sold a block of company shares totaling $50,034. This transaction occurred against a backdrop of positive operational news, as the utility reported strong Q1 2026 earnings and revenue that surpassed analyst expectations. Furthermore, key corporate governance updates were approved by s…
Director Richard Lee Boger sold a substantial amount of company stock on May 19, 2026. This transaction occurred against a backdrop of corporate adjustments for Gray Media, Inc., including revenue surpassing expectations but an earnings per share (EPS) miss in the first quarter. Furthermore, analysts have adjusted price targets following softer adv…
The Chief Financial Officer of Strategy Inc (MSTR), Andrew Kang, recently sold a significant block of company stock. These sales were executed pursuant to a prearranged Rule 10b5-1 plan and were primarily intended to cover tax withholding obligations related to previously vested equity awards. This transaction occurs while MSTR shares have seen dec…
U.S. Secretary of State Marco Rubio will convene with NATO foreign ministers in Helsingborg, Sweden, for his first meeting with the alliance since President Donald Trump publicly questioned NATO amid divisions over the Iran war. Rubio said Trump was "very disappointed" with some allies, singling out Spain for denying use of bases, as Washington ann…
Andrew Martin Johnson, Chief Financial Officer and Chief Legal Officer of AST SpaceMobile, Inc., executed a transaction selling 5,000 shares of Class A Common Stock on May 20, 2026, totaling $451,250. This sale was reported as being primarily intended to cover anticipated tax liabilities. The divestment occurs against the backdrop of significant ma…
Fennec Pharmaceuticals announced new independent research findings on PEDMARK®, its FDA-approved treatment to reduce cisplatin-induced ototoxicity, will be presented at the 2026 ASCO Annual Meeting. The studies demonstrate PEDMARK's safety, efficacy, and feasibility for use beyond pediatric populations, including adolescent, young adult, and adult …
A director at Star Equity Holdings, Inc. recently acquired several thousand dollars worth of the company's common stock over two days. This activity was reported via Form 4 filings. Beyond the personal transactions, the article details multiple corporate actions, including a settlement of restricted stock units into preferred shares, an agreement a…
Director Timothy Harned sold $47,300 worth of Vuzix Corp stock on May 21, 2026. This transaction occurred as the company's stock trades near its 52-week high following significant gains. Separately, Vuzix reported Q1 2026 earnings with an EPS of -$0.09 and revenue of $1.4 million, while also highlighting its waveguide solutions for defense applicat…
Geoffrey G. Ribar, a director at Everspin Technologies Inc., executed a sale of company shares totaling $793,578 on May 20, 2026. This transaction occurs amid significant corporate activity for the firm, including an earnings surprise and a major defense contract award. While some analysts view the stock as overvalued and others point to its primar…
Biogen and Denali Therapeutics announced that the Phase 2b LUMA study evaluating BIIB122 (DNL151), a LRRK2 inhibitor, in early-stage idiopathic Parkinson's disease failed to meet its primary and secondary endpoints, showing no slowing of disease progression. Consequently, they will discontinue BIIB122 development for idiopathic Parkinson's disease,…
Star Equity Holdings, Inc.'s CEO, Jeffrey E. Eberwein, engaged in several transactions to purchase company common stock between May 19 and May 21, 2026, accumulating an investment of $189,123. This activity occurs alongside other corporate developments, including the establishment of a sales agreement for preferred shares and updates to executive c…
Director Walter C. Rakowich recently sold a block of shares in Iron Mountain Inc. (NYSE: IRM) as part of a pre-scheduled trading plan. This insider activity is reported alongside the company's highly positive first quarter 2026 earnings release, where both revenue and earnings per share significantly beat analyst expectations.
Progyny's CFO, Mark S. Livingston, sold a portion of his common stock shares on May 20, 2026. This transaction occurred against a backdrop of positive company performance, including first-quarter results that exceeded market expectations and subsequent upgrades from major financial institutions regarding the firm's growth potential.
Eric Richard Remer, the CEO of EverCommerce Inc., executed multiple sales of company stock totaling $196,569 over three days in May. These actions occurred while the underlying stock saw a notable weekly gain of 9.65%. Separately, the firm reported mixed results for its first-quarter earnings in 2026, with revenue slightly exceeding expectations bu…
FormFactor Inc. (NASDAQ:FORM) announced a significant insider sale when one of its directors sold 3,250 shares of common stock in May 2026. This transaction occurred despite the company having recently reported robust first-quarter financial results and receiving several analyst upgrades. The report notes that while management activity is visible, …
Neurocrine Biosciences director Kevin Gorman sold approximately $37.8 million worth of common stock on May 19, 2026. This transaction was executed under a Rule 10b5-1 trading plan and included both the sale of existing shares and the exercise of options. These sales occurred against a backdrop of positive company developments for Neurocrine, includ…
SpaceX plans to launch the 12th uncrewed test flight of its Starship system on May 21, deploying a redesigned Starship V3 and an upgraded Super Heavy booster from a new Texas launch pad. The vehicle family has experienced a mix of early explosions and incremental successes across prior flights, including the first mock satellite deployments and a c…
Apple has asked the U.S. Supreme Court to review a lower court's civil contempt finding tied to fees it charged on some purchases routed to third-party payment systems. The move escalates litigation with Epic Games, which sued in 2020 over Apple's control of in-app transactions and app distribution on iOS. Central issues include a 2021 injunction r…
The Chief Executive Officer of Porch Group, Inc., Matt Ehrlichman, sold a substantial block of common shares in May 2026. This transaction was necessary to cover tax withholding related to vested performance-based restricted stock unit awards. Separately, the company reported mixed first-quarter results for 2026, achieving an earnings per share (EP…
Fortune Brands Innovations director, Edward P. Garden, recently purchased a substantial amount of the company's common stock, totaling over $2 million. This insider buying activity occurs while the stock is trading near its 52-week low and following disappointing Q1 earnings reports for the corporation. The purchase suggests internal belief in the …
